Medibank Private lifts profit and dividend in first half 2026

A man in a hospital bed on a drip gives a thumbs up sign.

The Medibank Private Ltd (ASX: MPL) share price is in focus today after the health insurer reported a 6.0% rise in group operating profit to $381.7 million for the half year to 31 December 2025, and lifted its fully franked interim dividend by 6.4% to 8.3 cents per share.

What did Medibank report?

  • Group revenue from external customers rose 5.5% to $4,503.5 million
  • Group operating profit increased 6.0% to $381.7 million
  • Underlying net profit after tax (NPAT) was largely flat at $297.8 million
  • Medibank Health segment profit jumped 28.5% to $48.3 million, now around 13% of group profit
  • Interim fully franked dividend up 6.4% to 8.3 cents per share
  • Net resident policyholder growth of 1.9% (+38,300 over 12 months)

What else do investors need to know?

Medibank continued to expand its health services, completing the acquisition of Better Medical for $163.5 million and increasing the number of national clinics. More than half of resident policyholders (55%) are now engaged with health and wellbeing services, while digital offerings and Live Better rewards programs gained traction.

Customer retention slightly improved despite heightened competition and industry switching rates. The business also delivered productivity gains and rolled out new AI technology to streamline customer and claims experiences.

What’s next for Medibank?

The company is on track to meet its FY26 outlook with a disciplined approach to growth, targeting further policyholder gains, steady expense management, and investment in new products and digital health offerings. Medibank is also focused on scaling its primary care network and health services, with both organic growth and a healthy pipeline of potential acquisitions.

Looking further ahead, management reaffirmed its goals to increase group earnings, expand in health, and achieve its long-term aspirations to 2030, underpinned by continued customer engagement and innovation.

Medibank share price snapshot

Over the past 12 months, Medibank shares have risen 21%, outperforming the S&P/ASX 200 Index (ASX: XJO) which has increased 7% over the same period.

View Original Announcement

The post Medibank Private lifts profit and dividend in first half 2026 appeared first on The Motley Fool Australia.

Should you invest $1,000 in Medibank Private Ltd right now?

Before you buy Medibank Private Ltd shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Medibank Private Ltd wasn’t one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys…

* Returns as of 1 Jan 2026

.custom-cta-button p {
margin-bottom: 0 !important;
}

More reading

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.